AIDS 2021 Sep 14. Epub 2021 Sep 14.
Inserm 1219, University of Bordeaux, IRD, Bordeaux, France PACCI/ANRS Research Center Département de Dermatologie et Maladies Infectieuses, Université Felix Houphouët Boigny, Abidjan, Côte d'Ivoire AP-HP, CHU Necker Enfants Malades, Université Paris Descartes, Paris, France CeDReS, CHU de Treichville, Abidjan, Côte d'Ivoire Faculté de Médecine, Université Paris Descartes, Paris AP-HP Paris Saclay, Hôpital Bicêtre, Clinical Immunology Department Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IDMIT/IMVA-HB), Le Kremlin Bicêtre, France.
Background: Data on HIV-1 controllers in Africa are scarce. We report the proportion of HIV-1 controllers in a group of adults prospectively monitored with frequent viral load measurements as part of a clinical trial in West Africa.
Methods: For the Temprano trial, antiretroviral therapy (ART)-naïve HIV-1 infected adults with no criteria for starting ART were randomized to start ART immediately or defer ART until the WHO starting criteria were met. Read More